Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The use of aprepitant in brachioradial pruritus.

Ally MS, Gamba CS, Peng DH, Tang JY.

JAMA Dermatol. 2013 May;149(5):627-8. doi: 10.1001/jamadermatol.2013.170. No abstract available.

PMID:
23677105
2.

Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.

Jiménez Gallo D, Albarrán Planelles C, Linares Barrios M, Fernández Anguita MJ, Márquez Enríquez J, Rodríguez Mateos ME.

Dermatol Ther. 2014 May-Jun;27(3):178-82. doi: 10.1111/dth.12113. Epub 2013 Dec 2.

PMID:
24517320
3.

Effect of topical pramoxine on experimentally induced pruritus in humans.

Yosipovitch G, Maibach HI.

J Am Acad Dermatol. 1997 Aug;37(2 Pt 1):278-80. No abstract available.

PMID:
9270522
4.

Pregabalin treatment of three cases with brachioradial pruritus.

Atış G, Bilir Kaya B.

Dermatol Ther. 2017 Mar;30(2). doi: 10.1111/dth.12459. Epub 2017 Feb 6.

PMID:
28168835
5.

[Brachioradial pruritus effectively treated with gabapentin].

Uldall Pallesen KA, Bygum A.

Ugeskr Laeger. 2012 Jun 25;174(26):1830-1. Danish.

PMID:
22735123
6.

Screening topical antipruritics: a histamine-induced itch human model.

Zhai H, Simion FA, Abrutyn E, Koehler AM, Maibach HI.

Skin Pharmacol Appl Skin Physiol. 2002 Jul-Aug;15(4):213-7.

PMID:
12218282
7.

Brachioradial pruritus in a 47-year-old woman treated with pregabalin.

Vestita M, Cerbone L, Calista D.

G Ital Dermatol Venereol. 2016 Dec;151(6):727-728. No abstract available.

PMID:
27824228
8.

Topical non-peptide antagonists of sensory neurotransmitters substance P and CGRP do not modify patch test and prick test reactions: a vehicle-controlled, double-blind pilot study.

Wallengren J, Edvinsson L.

Arch Dermatol Res. 2014 Jul;306(5):505-9. doi: 10.1007/s00403-014-1451-0. Epub 2014 Feb 14.

PMID:
24525842
9.

Capsaicin 8% cutaneous patch: a promising treatment for brachioradial pruritus?

Zeidler C, Lüling H, Dieckhöfer A, Osada N, Schedel F, Steinke S, Augustin M, Ständer S.

Br J Dermatol. 2015 Jun;172(6):1669-71. doi: 10.1111/bjd.13501. Epub 2015 Apr 13. No abstract available. Erratum in: Br J Dermatol. 2016 Jul;175(1):227.

PMID:
25354282
10.

Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma.

Booken N, Heck M, Nicolay JP, Klemke CD, Goerdt S, Utikal J.

Br J Dermatol. 2011 Mar;164(3):665-7. doi: 10.1111/j.1365-2133.2010.10108.x. Epub 2011 Jan 28. No abstract available.

PMID:
21039410
11.

[Brachioradial pruritus revealing cervicomedullary astrocytoma and treated with 8% capsaicin patches].

Hardy J, Uthurriague C, Bibas N, Bon E, Paul C, Nougué J.

Ann Dermatol Venereol. 2014 May;141(5):374-5. doi: 10.1016/j.annder.2014.01.011. Epub 2014 Feb 24. French. No abstract available.

PMID:
24835651
12.

Aprepitant in the treatment of refractory pruritus secondary to cutaneous T-cell lymphoma.

Borja-Consigliere HA, López-Pestaña A, Vidal-Manceñido MJ, Tuneu-Valls A.

Actas Dermosifiliogr. 2014 Sep;105(7):716-8. doi: 10.1016/j.ad.2013.07.007. Epub 2013 Oct 16. English, Spanish. No abstract available.

PMID:
24139470
13.

Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study.

Santini D, Vincenzi B, Guida FM, Imperatori M, Schiavon G, Venditti O, Frezza AM, Berti P, Tonini G.

Lancet Oncol. 2012 Oct;13(10):1020-4. doi: 10.1016/S1470-2045(12)70373-X. Epub 2012 Sep 18.

PMID:
22995650
14.

Topical aprepitant in clinical and experimental pruritus.

Wallengren J.

Arch Dermatol. 2012 Aug;148(8):957-9. doi: 10.1001/archdermatol.2012.1018. No abstract available.

PMID:
22911202
15.

Botulinum A toxin and brachioradial pruritus.

Kavanagh GM, Tidman MJ.

Br J Dermatol. 2012 May;166(5):1147. doi: 10.1111/j.1365-2133.2011.10749.x. Epub 2012 Mar 2. No abstract available.

PMID:
22098339
16.

Aprepitant for erlotinib-induced pruritus.

Vincenzi B, Tonini G, Santini D.

N Engl J Med. 2010 Jul 22;363(4):397-8. doi: 10.1056/NEJMc1003937. No abstract available.

17.

More on aprepitant for erlotinib-induced pruritus.

Mir O, Blanchet B, Goldwasser F.

N Engl J Med. 2011 Feb 3;364(5):487. doi: 10.1056/NEJMc1013027#SA2. No abstract available.

PMID:
21288111
18.

[Aprepitant and pruritus--comment].

Manasek V.

Klin Onkol. 2012;25(6):491-2. Czech. No abstract available.

PMID:
23346639
19.

Aprepitant: Evidence of its effectiveness in patients with refractory pruritus continues.

Torres T, Fernandes I, Selores M, Alves R, Lima M.

J Am Acad Dermatol. 2012 Jan;66(1):e14-5. doi: 10.1016/j.jaad.2011.01.016. No abstract available.

PMID:
22177649
20.

Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma.

Ladizinski B, Bazakas A, Olsen EA.

J Am Acad Dermatol. 2012 Nov;67(5):e198-9. doi: 10.1016/j.jaad.2012.02.008. No abstract available.

PMID:
23062910

Supplemental Content

Support Center